Related Experiment Video
Updated: Jul 28, 2026

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
Published on: January 3, 2020
Vertical mammaplasty: early complications after 250 personal consecutive cases
1Institut Médical Edith Cavell, Brussels, Belgium. mlej4240@euronet.be
This study on vertical mammaplasties found few complications, with seroma being most common. Larger, fatty breasts increase the risk of delayed healing, suggesting simpler procedures for obese patients.
Area of Science:
- Plastic Surgery
- Surgical Complications
Background:
- Complications in plastic surgery require careful management and analysis.
- Vertical mammaplasties are a common breast reduction technique.
Purpose of the Study:
- To analyze complications associated with vertical mammaplasties.
- To identify relationships between breast type, patient characteristics, and complication rates.
Main Methods:
- Prospective follow-up of 250 patients (476 breasts) undergoing vertical mammaplasties between 1990 and 1998.
- Detailed recording and analysis of all surgical complications.
Main Results:
- Seroma was the most frequent benign complication (5%).
- Hematomas occurred in 1.2% of mastopexy cases.
- Areola necrosis was rare (2 partial cases), but resulted in deformities.
- Healing complications occurred in 5.4% of cases, linked to breast size and fat content.
- Delayed healing was more common in larger, fatty breasts and after liposuction.
Conclusions:
- Vertical mammaplasties generally have a low complication rate.
- Larger, fatty breasts are associated with a higher risk of delayed healing.
- Simpler surgical options may be considered for obese patients to minimize risks.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025